Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database Article Swipe

PDF

Léa Hoisnard , Bénédicte Lebrun‐Vignes , Sébastien Maury , Matthieu Mahévas , Khalil El Karoui , Lydia Roy , Anissa Zarour , Marc Michel , José L. Cohen , Aurélien Amiot , Pascal Claudepierre , P. Wolkenstein , Philippe Grimbert , É. Sbidian ·

YOU? · · 2022 · Open Access · · DOI: https://doi.org/10.1038/s41598-022-10777-w

Related Topics

Medicine

Internal Medicine

Adverse Drug Reaction

Concepts

Ruxolitinib Tofacitinib Medicine Pharmacovigilance Adverse effect Janus kinase inhibitor Janus kinase Extramedullary hematopoiesis Adverse Event Reporting System Myelofibrosis Internal medicine Adverse drug reaction Database Pharmacology Drug Rheumatoid arthritis Haematopoiesis Stem cell Computer science Biology Cytokine Bone marrow Genetics

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1038/s41598-022-10777-w
PDF: https://www.nature.com/articles/s41598-022-10777-w.pdf
OA Status: gold
Cited By: 142
References: 40
Related Works: 10
OpenAlex ID: https://openalex.org/W4225416290

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4225416290

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1038/s41598-022-10777-w

Digital Object Identifier
Title: Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2022

Year of publication
Publication date: 2022-05-03

Full publication date if available
Authors: Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury, Matthieu Mahévas, Khalil El Karoui, Lydia Roy, Anissa Zarour, Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, P. Wolkenstein, Philippe Grimbert, É. Sbidian

List of authors in order
Landing page: https://doi.org/10.1038/s41598-022-10777-w

Publisher landing page
PDF URL: https://www.nature.com/articles/s41598-022-10777-w.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://www.nature.com/articles/s41598-022-10777-w.pdf

Direct OA link when available
Concepts: Ruxolitinib, Tofacitinib, Medicine, Pharmacovigilance, Adverse effect, Janus kinase inhibitor, Janus kinase, Extramedullary hematopoiesis, Adverse Event Reporting System, Myelofibrosis, Internal medicine, Adverse drug reaction, Database, Pharmacology, Drug, Rheumatoid arthritis, Haematopoiesis, Stem cell, Computer science, Biology, Cytokine, Bone marrow, Genetics

Top concepts (fields/topics) attached by OpenAlex
Cited by: 142

Total citation count in OpenAlex
Citations by year (recent): 2025: 49, 2024: 49, 2023: 35, 2022: 8

Per-year citation counts (last 5 years)
References (count): 40

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4225416290
doi	https://doi.org/10.1038/s41598-022-10777-w
ids.doi	https://doi.org/10.1038/s41598-022-10777-w
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/35504889
ids.openalex	https://openalex.org/W4225416290
fwci	30.96336352
mesh[0].qualifier_ui
mesh[0].descriptor_ui	D001327
mesh[0].is_major_topic	True
mesh[0].qualifier_name
mesh[0].descriptor_name	Autoimmune Diseases
mesh[1].qualifier_ui
mesh[1].descriptor_ui	D016208
mesh[1].is_major_topic	False
mesh[1].qualifier_name
mesh[1].descriptor_name	Databases, Factual
mesh[2].qualifier_ui
mesh[2].descriptor_ui	D006801
mesh[2].is_major_topic	False
mesh[2].qualifier_name
mesh[2].descriptor_name	Humans
mesh[3].qualifier_ui	Q000009
mesh[3].descriptor_ui	D000075242
mesh[3].is_major_topic	True
mesh[3].qualifier_name	adverse effects
mesh[3].descriptor_name	Janus Kinase Inhibitors
mesh[4].qualifier_ui
mesh[4].descriptor_ui	D060735
mesh[4].is_major_topic	False
mesh[4].qualifier_name
mesh[4].descriptor_name	Pharmacovigilance
mesh[5].qualifier_ui
mesh[5].descriptor_ui	D014944
mesh[5].is_major_topic	False
mesh[5].qualifier_name
mesh[5].descriptor_name	World Health Organization
mesh[6].qualifier_ui
mesh[6].descriptor_ui	D001327
mesh[6].is_major_topic	True
mesh[6].qualifier_name
mesh[6].descriptor_name	Autoimmune Diseases
mesh[7].qualifier_ui
mesh[7].descriptor_ui	D016208
mesh[7].is_major_topic	False
mesh[7].qualifier_name
mesh[7].descriptor_name	Databases, Factual
mesh[8].qualifier_ui
mesh[8].descriptor_ui	D006801
mesh[8].is_major_topic	False
mesh[8].qualifier_name
mesh[8].descriptor_name	Humans
mesh[9].qualifier_ui	Q000009
mesh[9].descriptor_ui	D000075242
mesh[9].is_major_topic	True
mesh[9].qualifier_name	adverse effects
mesh[9].descriptor_name	Janus Kinase Inhibitors
mesh[10].qualifier_ui
mesh[10].descriptor_ui	D060735
mesh[10].is_major_topic	False
mesh[10].qualifier_name
mesh[10].descriptor_name	Pharmacovigilance
mesh[11].qualifier_ui
mesh[11].descriptor_ui	D014944
mesh[11].is_major_topic	False
mesh[11].qualifier_name
mesh[11].descriptor_name	World Health Organization
type	article
title	Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
biblio.issue	1
biblio.volume	12
biblio.last_page	7140
biblio.first_page	7140
topics[0].id	https://openalex.org/T11943
topics[0].field.id	https://openalex.org/fields/30
topics[0].field.display_name	Pharmacology, Toxicology and Pharmaceutics
topics[0].score	0.9908999800682068
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/3005
topics[0].subfield.display_name	Toxicology
topics[0].display_name	Pharmacovigilance and Adverse Drug Reactions
topics[1].id	https://openalex.org/T10200
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9898999929428101
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2745
topics[1].subfield.display_name	Rheumatology
topics[1].display_name	Rheumatoid Arthritis Research and Therapies
topics[2].id	https://openalex.org/T11117
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9891999959945679
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2736
topics[2].subfield.display_name	Pharmacology
topics[2].display_name	Drug-Induced Adverse Reactions
is_xpac	False
apc_list.value	1890
apc_list.currency	EUR
apc_list.value_usd	2190
apc_paid.value	1890
apc_paid.currency	EUR
apc_paid.value_usd	2190
concepts[0].id	https://openalex.org/C2776112149
concepts[0].level	4
concepts[0].score	0.9405184984207153
concepts[0].wikidata	https://www.wikidata.org/wiki/Q7383611
concepts[0].display_name	Ruxolitinib
concepts[1].id	https://openalex.org/C2778886723
concepts[1].level	3
concepts[1].score	0.9330089092254639
concepts[1].wikidata	https://www.wikidata.org/wiki/Q3530324
concepts[1].display_name	Tofacitinib
concepts[2].id	https://openalex.org/C71924100
concepts[2].level	0
concepts[2].score	0.9140875339508057
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[2].display_name	Medicine
concepts[3].id	https://openalex.org/C57658597
concepts[3].level	3
concepts[3].score	0.8816495537757874
concepts[3].wikidata	https://www.wikidata.org/wiki/Q1550789
concepts[3].display_name	Pharmacovigilance
concepts[4].id	https://openalex.org/C197934379
concepts[4].level	2
concepts[4].score	0.6030938625335693
concepts[4].wikidata	https://www.wikidata.org/wiki/Q2047938
concepts[4].display_name	Adverse effect
concepts[5].id	https://openalex.org/C2776233030
concepts[5].level	4
concepts[5].score	0.5204744338989258
concepts[5].wikidata	https://www.wikidata.org/wiki/Q17149812
concepts[5].display_name	Janus kinase inhibitor
concepts[6].id	https://openalex.org/C112392421
concepts[6].level	3
concepts[6].score	0.5109207034111023
concepts[6].wikidata	https://www.wikidata.org/wiki/Q903451
concepts[6].display_name	Janus kinase
concepts[7].id	https://openalex.org/C2778080410
concepts[7].level	4
concepts[7].score	0.508564829826355
concepts[7].wikidata	https://www.wikidata.org/wiki/Q5422215
concepts[7].display_name	Extramedullary hematopoiesis
concepts[8].id	https://openalex.org/C2777105317
concepts[8].level	3
concepts[8].score	0.4824312627315521
concepts[8].wikidata	https://www.wikidata.org/wiki/Q4686710
concepts[8].display_name	Adverse Event Reporting System
concepts[9].id	https://openalex.org/C2780076729
concepts[9].level	3
concepts[9].score	0.4725978970527649
concepts[9].wikidata	https://www.wikidata.org/wiki/Q1752571
concepts[9].display_name	Myelofibrosis
concepts[10].id	https://openalex.org/C126322002
concepts[10].level	1
concepts[10].score	0.4576590955257416
concepts[10].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[10].display_name	Internal medicine
concepts[11].id	https://openalex.org/C2780542314
concepts[11].level	3
concepts[11].score	0.45414257049560547
concepts[11].wikidata	https://www.wikidata.org/wiki/Q45959
concepts[11].display_name	Adverse drug reaction
concepts[12].id	https://openalex.org/C77088390
concepts[12].level	1
concepts[12].score	0.45393431186676025
concepts[12].wikidata	https://www.wikidata.org/wiki/Q8513
concepts[12].display_name	Database
concepts[13].id	https://openalex.org/C98274493
concepts[13].level	1
concepts[13].score	0.24287563562393188
concepts[13].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[13].display_name	Pharmacology
concepts[14].id	https://openalex.org/C2780035454
concepts[14].level	2
concepts[14].score	0.1854289174079895
concepts[14].wikidata	https://www.wikidata.org/wiki/Q8386
concepts[14].display_name	Drug
concepts[15].id	https://openalex.org/C2777575956
concepts[15].level	2
concepts[15].score	0.15286821126937866
concepts[15].wikidata	https://www.wikidata.org/wiki/Q187255
concepts[15].display_name	Rheumatoid arthritis
concepts[16].id	https://openalex.org/C109159458
concepts[16].level	3
concepts[16].score	0.0
concepts[16].wikidata	https://www.wikidata.org/wiki/Q919283
concepts[16].display_name	Haematopoiesis
concepts[17].id	https://openalex.org/C28328180
concepts[17].level	2
concepts[17].score	0.0
concepts[17].wikidata	https://www.wikidata.org/wiki/Q48196
concepts[17].display_name	Stem cell
concepts[18].id	https://openalex.org/C41008148
concepts[18].level	0
concepts[18].score	0.0
concepts[18].wikidata	https://www.wikidata.org/wiki/Q21198
concepts[18].display_name	Computer science
concepts[19].id	https://openalex.org/C86803240
concepts[19].level	0
concepts[19].score	0.0
concepts[19].wikidata	https://www.wikidata.org/wiki/Q420
concepts[19].display_name	Biology
concepts[20].id	https://openalex.org/C2778690821
concepts[20].level	2
concepts[20].score	0.0
concepts[20].wikidata	https://www.wikidata.org/wiki/Q212354
concepts[20].display_name	Cytokine
concepts[21].id	https://openalex.org/C2780007613
concepts[21].level	2
concepts[21].score	0.0
concepts[21].wikidata	https://www.wikidata.org/wiki/Q546523
concepts[21].display_name	Bone marrow
concepts[22].id	https://openalex.org/C54355233
concepts[22].level	1
concepts[22].score	0.0
concepts[22].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[22].display_name	Genetics
keywords[0].id	https://openalex.org/keywords/ruxolitinib
keywords[0].score	0.9405184984207153
keywords[0].display_name	Ruxolitinib
keywords[1].id	https://openalex.org/keywords/tofacitinib
keywords[1].score	0.9330089092254639
keywords[1].display_name	Tofacitinib
keywords[2].id	https://openalex.org/keywords/medicine
keywords[2].score	0.9140875339508057
keywords[2].display_name	Medicine
keywords[3].id	https://openalex.org/keywords/pharmacovigilance
keywords[3].score	0.8816495537757874
keywords[3].display_name	Pharmacovigilance
keywords[4].id	https://openalex.org/keywords/adverse-effect
keywords[4].score	0.6030938625335693
keywords[4].display_name	Adverse effect
keywords[5].id	https://openalex.org/keywords/janus-kinase-inhibitor
keywords[5].score	0.5204744338989258
keywords[5].display_name	Janus kinase inhibitor
keywords[6].id	https://openalex.org/keywords/janus-kinase
keywords[6].score	0.5109207034111023
keywords[6].display_name	Janus kinase
keywords[7].id	https://openalex.org/keywords/extramedullary-hematopoiesis
keywords[7].score	0.508564829826355
keywords[7].display_name	Extramedullary hematopoiesis
keywords[8].id	https://openalex.org/keywords/adverse-event-reporting-system
keywords[8].score	0.4824312627315521
keywords[8].display_name	Adverse Event Reporting System
keywords[9].id	https://openalex.org/keywords/myelofibrosis
keywords[9].score	0.4725978970527649
keywords[9].display_name	Myelofibrosis
keywords[10].id	https://openalex.org/keywords/internal-medicine
keywords[10].score	0.4576590955257416
keywords[10].display_name	Internal medicine
keywords[11].id	https://openalex.org/keywords/adverse-drug-reaction
keywords[11].score	0.45414257049560547
keywords[11].display_name	Adverse drug reaction
keywords[12].id	https://openalex.org/keywords/database
keywords[12].score	0.45393431186676025
keywords[12].display_name	Database
keywords[13].id	https://openalex.org/keywords/pharmacology
keywords[13].score	0.24287563562393188
keywords[13].display_name	Pharmacology
keywords[14].id	https://openalex.org/keywords/drug
keywords[14].score	0.1854289174079895
keywords[14].display_name	Drug
keywords[15].id	https://openalex.org/keywords/rheumatoid-arthritis
keywords[15].score	0.15286821126937866
keywords[15].display_name	Rheumatoid arthritis
language	en
locations[0].id	doi:10.1038/s41598-022-10777-w
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S196734849
locations[0].source.issn	2045-2322
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2045-2322
locations[0].source.is_core	True
locations[0].source.is_in_doaj	True
locations[0].source.display_name	Scientific Reports
locations[0].source.host_organization	https://openalex.org/P4310319908
locations[0].source.host_organization_name	Nature Portfolio
locations[0].source.host_organization_lineage	https://openalex.org/P4310319908, https://openalex.org/P4310319965
locations[0].source.host_organization_lineage_names	Nature Portfolio, Springer Nature
locations[0].license	cc-by
locations[0].pdf_url	https://www.nature.com/articles/s41598-022-10777-w.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Scientific Reports
locations[0].landing_page_url	https://doi.org/10.1038/s41598-022-10777-w
locations[1].id	pmid:35504889
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	Scientific reports
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/35504889
locations[2].id	pmh:oai:doaj.org/article:2ca98a65657442a48f5704f32414808b
locations[2].is_oa	True
locations[2].source.id	https://openalex.org/S4306401280
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	DOAJ (DOAJ: Directory of Open Access Journals)
locations[2].source.host_organization
locations[2].source.host_organization_name
locations[2].license	cc-by-sa
locations[2].pdf_url
locations[2].version	submittedVersion
locations[2].raw_type	article
locations[2].license_id	https://openalex.org/licenses/cc-by-sa
locations[2].is_accepted	False
locations[2].is_published	False
locations[2].raw_source_name	Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
locations[2].landing_page_url	https://doaj.org/article/2ca98a65657442a48f5704f32414808b
locations[3].id	pmh:oai:pubmedcentral.nih.gov:9065106
locations[3].is_oa	True
locations[3].source.id	https://openalex.org/S2764455111
locations[3].source.issn
locations[3].source.type	repository
locations[3].source.is_oa	False
locations[3].source.issn_l
locations[3].source.is_core	False
locations[3].source.is_in_doaj	False
locations[3].source.display_name	PubMed Central
locations[3].source.host_organization	https://openalex.org/I1299303238
locations[3].source.host_organization_name	National Institutes of Health
locations[3].source.host_organization_lineage	https://openalex.org/I1299303238
locations[3].license	other-oa
locations[3].pdf_url
locations[3].version	submittedVersion
locations[3].raw_type	Text
locations[3].license_id	https://openalex.org/licenses/other-oa
locations[3].is_accepted	False
locations[3].is_published	False
locations[3].raw_source_name	Sci Rep
locations[3].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/9065106
indexed_in	crossref, doaj, pubmed
authorships[0].author.id	https://openalex.org/A5002474461
authorships[0].author.orcid	https://orcid.org/0000-0002-0921-5142
authorships[0].author.display_name	Léa Hoisnard
authorships[0].countries	FR
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[0].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[0].institutions[0].id	https://openalex.org/I4210097159
authorships[0].institutions[0].ror	https://ror.org/00pg5jh14
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I4210097159
authorships[0].institutions[0].country_code	FR
authorships[0].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[0].institutions[1].id	https://openalex.org/I4210105451
authorships[0].institutions[1].ror	https://ror.org/00yyw0g86
authorships[0].institutions[1].type	other
authorships[0].institutions[1].lineage	https://openalex.org/I4210105451
authorships[0].institutions[1].country_code	FR
authorships[0].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[0].author_position	first
authorships[0].raw_author_name	Léa Hoisnard
authorships[0].is_corresponding	True
authorships[0].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[1].author.id	https://openalex.org/A5063177685
authorships[1].author.orcid	https://orcid.org/0000-0001-6676-5063
authorships[1].author.display_name	Bénédicte Lebrun‐Vignes
authorships[1].countries	FR
authorships[1].affiliations[0].institution_ids	https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705
authorships[1].affiliations[0].raw_affiliation_string	Department of Pharmacology, Pharmacovigilance Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, Paris, France
authorships[1].institutions[0].id	https://openalex.org/I4210097159
authorships[1].institutions[0].ror	https://ror.org/00pg5jh14
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I4210097159
authorships[1].institutions[0].country_code	FR
authorships[1].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[1].institutions[1].id	https://openalex.org/I4210121705
authorships[1].institutions[1].ror	https://ror.org/02mh9a093
authorships[1].institutions[1].type	healthcare
authorships[1].institutions[1].lineage	https://openalex.org/I4210097159, https://openalex.org/I4210121705
authorships[1].institutions[1].country_code	FR
authorships[1].institutions[1].display_name	Pitié-Salpêtrière Hospital
authorships[1].institutions[2].id	https://openalex.org/I39804081
authorships[1].institutions[2].ror	https://ror.org/02en5vm52
authorships[1].institutions[2].type	education
authorships[1].institutions[2].lineage	https://openalex.org/I39804081
authorships[1].institutions[2].country_code	FR
authorships[1].institutions[2].display_name	Sorbonne Université
authorships[1].author_position	middle
authorships[1].raw_author_name	Bénédicte Lebrun-Vignes
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Department of Pharmacology, Pharmacovigilance Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, Paris, France
authorships[2].author.id	https://openalex.org/A5011668592
authorships[2].author.orcid	https://orcid.org/0000-0002-1170-8683
authorships[2].author.display_name	Sébastien Maury
authorships[2].countries	FR
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[2].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[2].institutions[0].id	https://openalex.org/I4210097159
authorships[2].institutions[0].ror	https://ror.org/00pg5jh14
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I4210097159
authorships[2].institutions[0].country_code	FR
authorships[2].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[2].institutions[1].id	https://openalex.org/I4210105451
authorships[2].institutions[1].ror	https://ror.org/00yyw0g86
authorships[2].institutions[1].type	other
authorships[2].institutions[1].lineage	https://openalex.org/I4210105451
authorships[2].institutions[1].country_code	FR
authorships[2].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[2].author_position	middle
authorships[2].raw_author_name	Sébastien Maury
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[3].author.id	https://openalex.org/A5031127153
authorships[3].author.orcid	https://orcid.org/0000-0001-9913-7741
authorships[3].author.display_name	Matthieu Mahévas
authorships[3].countries	FR
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[3].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[3].institutions[0].id	https://openalex.org/I4210097159
authorships[3].institutions[0].ror	https://ror.org/00pg5jh14
authorships[3].institutions[0].type	healthcare
authorships[3].institutions[0].lineage	https://openalex.org/I4210097159
authorships[3].institutions[0].country_code	FR
authorships[3].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[3].institutions[1].id	https://openalex.org/I4210105451
authorships[3].institutions[1].ror	https://ror.org/00yyw0g86
authorships[3].institutions[1].type	other
authorships[3].institutions[1].lineage	https://openalex.org/I4210105451
authorships[3].institutions[1].country_code	FR
authorships[3].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[3].author_position	middle
authorships[3].raw_author_name	Matthieu Mahevas
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[4].author.id	https://openalex.org/A5088819374
authorships[4].author.orcid	https://orcid.org/0000-0002-2978-6698
authorships[4].author.display_name	Khalil El Karoui
authorships[4].countries	FR
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[4].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[4].institutions[0].id	https://openalex.org/I4210097159
authorships[4].institutions[0].ror	https://ror.org/00pg5jh14
authorships[4].institutions[0].type	healthcare
authorships[4].institutions[0].lineage	https://openalex.org/I4210097159
authorships[4].institutions[0].country_code	FR
authorships[4].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[4].institutions[1].id	https://openalex.org/I4210105451
authorships[4].institutions[1].ror	https://ror.org/00yyw0g86
authorships[4].institutions[1].type	other
authorships[4].institutions[1].lineage	https://openalex.org/I4210105451
authorships[4].institutions[1].country_code	FR
authorships[4].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[4].author_position	middle
authorships[4].raw_author_name	Khalil El Karoui
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[5].author.id	https://openalex.org/A5007454329
authorships[5].author.orcid	https://orcid.org/0000-0002-1833-9673
authorships[5].author.display_name	Lydia Roy
authorships[5].countries	FR
authorships[5].affiliations[0].institution_ids	https://openalex.org/I197681013, https://openalex.org/I4210097159
authorships[5].affiliations[0].raw_affiliation_string	Hematology Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital & Faculté de Santé, UPEC (Université Paris Est Créteil), 94010, Créteil, France
authorships[5].institutions[0].id	https://openalex.org/I4210097159
authorships[5].institutions[0].ror	https://ror.org/00pg5jh14
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I4210097159
authorships[5].institutions[0].country_code	FR
authorships[5].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[5].institutions[1].id	https://openalex.org/I197681013
authorships[5].institutions[1].ror	https://ror.org/05ggc9x40
authorships[5].institutions[1].type	education
authorships[5].institutions[1].lineage	https://openalex.org/I197681013
authorships[5].institutions[1].country_code	FR
authorships[5].institutions[1].display_name	Université Paris-Est Créteil
authorships[5].author_position	middle
authorships[5].raw_author_name	Lydia Roy
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Hematology Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital & Faculté de Santé, UPEC (Université Paris Est Créteil), 94010, Créteil, France
authorships[6].author.id	https://openalex.org/A5062128037
authorships[6].author.orcid
authorships[6].author.display_name	Anissa Zarour
authorships[6].countries	FR
authorships[6].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[6].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[6].institutions[0].id	https://openalex.org/I4210097159
authorships[6].institutions[0].ror	https://ror.org/00pg5jh14
authorships[6].institutions[0].type	healthcare
authorships[6].institutions[0].lineage	https://openalex.org/I4210097159
authorships[6].institutions[0].country_code	FR
authorships[6].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[6].institutions[1].id	https://openalex.org/I4210105451
authorships[6].institutions[1].ror	https://ror.org/00yyw0g86
authorships[6].institutions[1].type	other
authorships[6].institutions[1].lineage	https://openalex.org/I4210105451
authorships[6].institutions[1].country_code	FR
authorships[6].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[6].author_position	middle
authorships[6].raw_author_name	Anissa Zarour
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[7].author.id	https://openalex.org/A5056136082
authorships[7].author.orcid	https://orcid.org/0000-0002-9822-7400
authorships[7].author.display_name	Marc Michel
authorships[7].countries	FR
authorships[7].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[7].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[7].institutions[0].id	https://openalex.org/I4210097159
authorships[7].institutions[0].ror	https://ror.org/00pg5jh14
authorships[7].institutions[0].type	healthcare
authorships[7].institutions[0].lineage	https://openalex.org/I4210097159
authorships[7].institutions[0].country_code	FR
authorships[7].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[7].institutions[1].id	https://openalex.org/I4210105451
authorships[7].institutions[1].ror	https://ror.org/00yyw0g86
authorships[7].institutions[1].type	other
authorships[7].institutions[1].lineage	https://openalex.org/I4210105451
authorships[7].institutions[1].country_code	FR
authorships[7].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[7].author_position	middle
authorships[7].raw_author_name	Marc Michel
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[8].author.id	https://openalex.org/A5012996331
authorships[8].author.orcid	https://orcid.org/0000-0002-5077-6726
authorships[8].author.display_name	José L. Cohen
authorships[8].countries	FR
authorships[8].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[8].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[8].institutions[0].id	https://openalex.org/I4210097159
authorships[8].institutions[0].ror	https://ror.org/00pg5jh14
authorships[8].institutions[0].type	healthcare
authorships[8].institutions[0].lineage	https://openalex.org/I4210097159
authorships[8].institutions[0].country_code	FR
authorships[8].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[8].institutions[1].id	https://openalex.org/I4210105451
authorships[8].institutions[1].ror	https://ror.org/00yyw0g86
authorships[8].institutions[1].type	other
authorships[8].institutions[1].lineage	https://openalex.org/I4210105451
authorships[8].institutions[1].country_code	FR
authorships[8].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[8].author_position	middle
authorships[8].raw_author_name	José L. Cohen
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[9].author.id	https://openalex.org/A5038935670
authorships[9].author.orcid	https://orcid.org/0000-0001-6676-1222
authorships[9].author.display_name	Aurélien Amiot
authorships[9].countries	FR
authorships[9].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[9].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[9].institutions[0].id	https://openalex.org/I4210097159
authorships[9].institutions[0].ror	https://ror.org/00pg5jh14
authorships[9].institutions[0].type	healthcare
authorships[9].institutions[0].lineage	https://openalex.org/I4210097159
authorships[9].institutions[0].country_code	FR
authorships[9].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[9].institutions[1].id	https://openalex.org/I4210105451
authorships[9].institutions[1].ror	https://ror.org/00yyw0g86
authorships[9].institutions[1].type	other
authorships[9].institutions[1].lineage	https://openalex.org/I4210105451
authorships[9].institutions[1].country_code	FR
authorships[9].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[9].author_position	middle
authorships[9].raw_author_name	Aurélien Amiot
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[10].author.id	https://openalex.org/A5017486273
authorships[10].author.orcid	https://orcid.org/0000-0003-1911-0544
authorships[10].author.display_name	Pascal Claudepierre
authorships[10].countries	FR
authorships[10].affiliations[0].institution_ids	https://openalex.org/I197681013, https://openalex.org/I4394709234
authorships[10].affiliations[0].raw_affiliation_string	EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, EA7379, Paris Est Créteil University UPEC, 94010, Créteil, France
authorships[10].institutions[0].id	https://openalex.org/I4394709234
authorships[10].institutions[0].ror	https://ror.org/011gnc761
authorships[10].institutions[0].type	facility
authorships[10].institutions[0].lineage	https://openalex.org/I197681013, https://openalex.org/I4394709234
authorships[10].institutions[0].country_code
authorships[10].institutions[0].display_name	Epidemiology in dermatology and evaluation of therapeutics
authorships[10].institutions[1].id	https://openalex.org/I197681013
authorships[10].institutions[1].ror	https://ror.org/05ggc9x40
authorships[10].institutions[1].type	education
authorships[10].institutions[1].lineage	https://openalex.org/I197681013
authorships[10].institutions[1].country_code	FR
authorships[10].institutions[1].display_name	Université Paris-Est Créteil
authorships[10].author_position	middle
authorships[10].raw_author_name	Pascal Claudepierre
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, EA7379, Paris Est Créteil University UPEC, 94010, Créteil, France
authorships[11].author.id	https://openalex.org/A5029037831
authorships[11].author.orcid	https://orcid.org/0000-0001-8194-457X
authorships[11].author.display_name	P. Wolkenstein
authorships[11].countries	FR
authorships[11].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[11].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[11].institutions[0].id	https://openalex.org/I4210097159
authorships[11].institutions[0].ror	https://ror.org/00pg5jh14
authorships[11].institutions[0].type	healthcare
authorships[11].institutions[0].lineage	https://openalex.org/I4210097159
authorships[11].institutions[0].country_code	FR
authorships[11].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[11].institutions[1].id	https://openalex.org/I4210105451
authorships[11].institutions[1].ror	https://ror.org/00yyw0g86
authorships[11].institutions[1].type	other
authorships[11].institutions[1].lineage	https://openalex.org/I4210105451
authorships[11].institutions[1].country_code	FR
authorships[11].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[11].author_position	middle
authorships[11].raw_author_name	Pierre Wolkenstein
authorships[11].is_corresponding	False
authorships[11].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[12].author.id	https://openalex.org/A5035690548
authorships[12].author.orcid	https://orcid.org/0000-0002-8235-2864
authorships[12].author.display_name	Philippe Grimbert
authorships[12].countries	FR
authorships[12].affiliations[0].institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
authorships[12].affiliations[0].raw_affiliation_string	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[12].institutions[0].id	https://openalex.org/I4210097159
authorships[12].institutions[0].ror	https://ror.org/00pg5jh14
authorships[12].institutions[0].type	healthcare
authorships[12].institutions[0].lineage	https://openalex.org/I4210097159
authorships[12].institutions[0].country_code	FR
authorships[12].institutions[0].display_name	Assistance Publique – Hôpitaux de Paris
authorships[12].institutions[1].id	https://openalex.org/I4210105451
authorships[12].institutions[1].ror	https://ror.org/00yyw0g86
authorships[12].institutions[1].type	other
authorships[12].institutions[1].lineage	https://openalex.org/I4210105451
authorships[12].institutions[1].country_code	FR
authorships[12].institutions[1].display_name	Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
authorships[12].author_position	middle
authorships[12].raw_author_name	Philippe Grimbert
authorships[12].is_corresponding	False
authorships[12].raw_affiliation_strings	Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, 94010, Créteil, France
authorships[13].author.id	https://openalex.org/A5057668291
authorships[13].author.orcid	https://orcid.org/0000-0002-1267-5270
authorships[13].author.display_name	É. Sbidian
authorships[13].countries	FR
authorships[13].affiliations[0].institution_ids	https://openalex.org/I154526488, https://openalex.org/I4387156050
authorships[13].affiliations[0].raw_affiliation_string	INSERM, Centre d'Investigation Clinique 1430, 94010, Créteil, France
authorships[13].institutions[0].id	https://openalex.org/I4387156050
authorships[13].institutions[0].ror	https://ror.org/033z83z59
authorships[13].institutions[0].type	facility
authorships[13].institutions[0].lineage	https://openalex.org/I134560555, https://openalex.org/I154526488, https://openalex.org/I4387156050, https://openalex.org/I4412460029
authorships[13].institutions[0].country_code
authorships[13].institutions[0].display_name	Centre d’Investigation Clinique 1436
authorships[13].institutions[1].id	https://openalex.org/I154526488
authorships[13].institutions[1].ror	https://ror.org/02vjkv261
authorships[13].institutions[1].type	government
authorships[13].institutions[1].lineage	https://openalex.org/I154526488
authorships[13].institutions[1].country_code	FR
authorships[13].institutions[1].display_name	Inserm
authorships[13].author_position	last
authorships[13].raw_author_name	Emilie Sbidian
authorships[13].is_corresponding	False
authorships[13].raw_affiliation_strings	INSERM, Centre d'Investigation Clinique 1430, 94010, Créteil, France
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://www.nature.com/articles/s41598-022-10777-w.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11943
primary_topic.field.id	https://openalex.org/fields/30
primary_topic.field.display_name	Pharmacology, Toxicology and Pharmaceutics
primary_topic.score	0.9908999800682068
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/3005
primary_topic.subfield.display_name	Toxicology
primary_topic.display_name	Pharmacovigilance and Adverse Drug Reactions
related_works	https://openalex.org/W4389622627, https://openalex.org/W2752345645, https://openalex.org/W4254489547, https://openalex.org/W2556216061, https://openalex.org/W2248533790, https://openalex.org/W2896488923, https://openalex.org/W2113082323, https://openalex.org/W2915214480, https://openalex.org/W2905252141, https://openalex.org/W4254714199
cited_by_count	142
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	49
counts_by_year[1].year	2024
counts_by_year[1].cited_by_count	49
counts_by_year[2].year	2023
counts_by_year[2].cited_by_count	35
counts_by_year[3].year	2022
counts_by_year[3].cited_by_count	8
locations_count	4
best_oa_location.id	doi:10.1038/s41598-022-10777-w
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S196734849
best_oa_location.source.issn	2045-2322
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2045-2322
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	Scientific Reports
best_oa_location.source.host_organization	https://openalex.org/P4310319908
best_oa_location.source.host_organization_name	Nature Portfolio
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310319908, https://openalex.org/P4310319965
best_oa_location.source.host_organization_lineage_names	Nature Portfolio, Springer Nature
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://www.nature.com/articles/s41598-022-10777-w.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Scientific Reports
best_oa_location.landing_page_url	https://doi.org/10.1038/s41598-022-10777-w
primary_location.id	doi:10.1038/s41598-022-10777-w
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S196734849
primary_location.source.issn	2045-2322
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2045-2322
primary_location.source.is_core	True
primary_location.source.is_in_doaj	True
primary_location.source.display_name	Scientific Reports
primary_location.source.host_organization	https://openalex.org/P4310319908
primary_location.source.host_organization_name	Nature Portfolio
primary_location.source.host_organization_lineage	https://openalex.org/P4310319908, https://openalex.org/P4310319965
primary_location.source.host_organization_lineage_names	Nature Portfolio, Springer Nature
primary_location.license	cc-by
primary_location.pdf_url	https://www.nature.com/articles/s41598-022-10777-w.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Scientific Reports
primary_location.landing_page_url	https://doi.org/10.1038/s41598-022-10777-w
publication_date	2022-05-03
publication_year	2022
referenced_works	https://openalex.org/W2072488504, https://openalex.org/W2973019461, https://openalex.org/W3013398484, https://openalex.org/W2911925296, https://openalex.org/W3024020861, https://openalex.org/W1921689204, https://openalex.org/W2329371764, https://openalex.org/W2584430503, https://openalex.org/W2589237569, https://openalex.org/W2769707416, https://openalex.org/W2926455583, https://openalex.org/W3094882380, https://openalex.org/W2343866616, https://openalex.org/W3001373379, https://openalex.org/W2775284703, https://openalex.org/W2794126504, https://openalex.org/W2945228415, https://openalex.org/W3047229059, https://openalex.org/W3035616984, https://openalex.org/W3045268911, https://openalex.org/W2543549509, https://openalex.org/W2916179527, https://openalex.org/W2890221919, https://openalex.org/W2988672002, https://openalex.org/W3048071747, https://openalex.org/W2593565645, https://openalex.org/W2884158907, https://openalex.org/W2937719347, https://openalex.org/W2942576594, https://openalex.org/W3087665791, https://openalex.org/W2996587996, https://openalex.org/W2316089822, https://openalex.org/W2071099746, https://openalex.org/W2117335168, https://openalex.org/W3082892775, https://openalex.org/W2134007339, https://openalex.org/W2121743767, https://openalex.org/W2082276693, https://openalex.org/W2074289946, https://openalex.org/W2005366883
referenced_works_count	40
abstract_inverted_index
cited_by_percentile_year.max	100
cited_by_percentile_year.min	99
corresponding_author_ids	https://openalex.org/A5002474461
countries_distinct_count	1
institutions_distinct_count	14
corresponding_institution_ids	https://openalex.org/I4210097159, https://openalex.org/I4210105451
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.800000011920929
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.99968681
citation_normalized_percentile.is_in_top_1_percent	True
citation_normalized_percentile.is_in_top_10_percent	True